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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYInsertion of reporter cassettes into the Lgr5 locus has enabled the characterization ofmouse intestinal stem cells (ISCs). However, low cell
surface abundance of LGR5 protein and lack of high-affinity anti-LGR5 antibodies represent a roadblock to efficiently isolate human
colonic stem cells (hCoSCs). We set out to identify stem cell markers that would allow for purification of hCoSCs. In an unbiased
approach, membrane-enriched protein fractions derived from in vitro human colonic organoids were analyzed by quantitative mass
spectrometry. Protein tyrosine pseudokinase PTK7 specified a cell population within human colonic organoids characterized by highest
self-renewal and re-seeding capacity. Antibodies recognizing the extracellular domain of PTK7 allowed us to isolate and expand hCoSCs
directly from patient-derivedmucosa samples. Human PTK7+ cells display features of canonical Lgr5+ ISCs and include a fraction of cells
that undergo differentiation toward enteroendocrine lineage that resemble crypt label retaining cells (LRCs).INTRODUCTION
The epithelium that lines the small intestine and the
colon is in constant self-renewal with a life cycle of
3–4 days (Clevers, 2013a). Regeneration occurs from units
embedded within the submucosa known as crypts, each
containing about 6–10 intestinal stem cells (ISCs) (Clevers,
2013a). Differentiated epithelial cells reside at the surface.
The biology of mouse ISCs has been intensively studied
in recent years. They express Lgr5, a receptor for the WNT
pathway agonist R-Spondin 1 (R-SPO) (Barker et al., 2007;
de Lau et al., 2011; Leushacke and Barker, 2014). Mouse
Lgr5+ cells are rapidly dividing multipotent stem cells
that reside at the bottommost positions of the small intes-
tine and colonic crypts. Under culturing conditions that
simulate the stem cell niche, mouse Lgr5+ cells form 3D
structures in vitro, known as organoids (Sato et al., 2009).
The progeny of ISCs, transit amplifying cells or progeni-
tors,will eventually give rise to themajorityof differentiated
cells as theymigrate upward along the crypt axis. Recently it
was shown that a fraction of Lgr5+ cells remains relatively
slow proliferating and differentiates directly into less abun-
dant differentiated lineages such as Paneth or enteroendo-
crine cells. This Lgr5+ cell subpopulation can be experimen-
tally recognized by the retention of molecules that label
DNA and therefore has been known as label retaining cells
(LRCs) (Clevers, 2013b; Potten et al., 1974). They are charac-
terizedby co-expressionof ISC-specific genes andmarkers of
Paneth cells and enteroendocrine lineages (Buczacki et al.,
2013; Gru¨n et al., 2015). LRCs are fated to differentiate;Stem Cellnevertheless, under certain conditions, such as damage of
the cycling ISC pool, they act as facultative stem cells and
contribute to the regeneration of the intestinal epithelium
(Buczacki et al., 2013). Mouse LRCs also expand as in vitro
organoids (Buczacki et al., 2013).
There is a growing interest inunderstanding thebiologyof
human colonic stem cells (hCoSCs), as it is widely believed
that they play key roles in various human intestinal disor-
ders (Barker et al., 2009). Furthermore, a better understand-
ing of this cell population is key to develop therapeutic
approaches to regenerate disease-affected tissue (Yui et al.,
2012). We recently showed that in media containing
WNT3a, R-SPO, EGF, and Noggin (WREN media) human
colonic crypts form organoids that expand as undifferenti-
ated 3D cell cultures (Jung et al., 2011). However, only
around 5%–6% of the cells within these cultures remain as
multipotent stem cells. We searched for surface markers
that identify bona fide hCoSCs from human organoid cul-
tures. We characterize protein tyrosine pseudokinase 7
(PTK7) as a hCoSCmarker that allows purification and opti-
mized ex vivo expansion of self-renewing multipotent
hCoSCs.
RESULTS
Quantitative Mass Spectrometry Analyses of Human
Colon Organoid-Derived Membrane Proteins
We searched for surface markers that would enable discrim-
ination of distinct cell populations in human colon organo-
ids (Jung et al., 2011). By quantitative mass spectrometryReports j Vol. 5 j 979–987 j December 8, 2015 j ª2015 The Authors 979
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Figure 1. Quantitative Mass Spectrometry Reveals PTK7 Is Enriched in Ex Vivo Cultured hCoSCs and Specifies Organoid Cells with
Highest Self-Renewal Capacity
(A) Experimental scheme: Human colonic organoids were cultured under stem cell (WREN, STEM) or differentiation (EN, DIFF) conditions.
Differentiation was induced for 72 hr. After isolation of membrane-enriched protein fractions, samples were subjected to quantitative mass
spectrometry (LC-MS-MS).
(legend continued on next page)
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(q-LC-MS-MS) analyses, we compared plasma membrane-
enriched protein fractions of human colon crypts cultured
in stem (WREN) versus differentiated (media containing
EGF and Noggin [EN]) conditions (Jung et al., 2011) (Fig-
ure 1A). Whereas this experimental setting may not exactly
reflect lineage specification and differentiation present
in vivo,we reasoned that a subset of ISCmarker geneswould
be differentially expressed between the two conditions. We
identified 261 proteins that were enrichedmore than 2-fold
in stem cells and 119 proteins in differentiated cells (t test, p
value < 0.01; Table S1). Proteins significantly enriched in
WREN or EN human colonic organoid cells (t test signifi-
cance labeled as ‘‘+’’ in Table S1) were also enriched inmem-
brane proteins when compared with the human proteome
(Table S2). Multiple markers of enterocytes, mucosecreting,
and enteroendocrine cells were upregulated in EN organoid
cells, includingMUC2, FABP1, orDPP4 (Figure1B; Table S1).
Concomitantly, several previously identified ISC markers
such as CD44 (Gracz et al., 2013), SLC12A2 (Whissell
et al., 2014), andEPHB2 (Merlos-Sua´rez et al., 2011)were up-
regulated underWREN conditions (Figure 1B; Table S1). We
focused our attention on PTK7, a transmembrane pseudoki-
nase that regulates canonical and non-canonical WNT
signaling during embryo development (Puppo et al., 2011)
(Figure 1B). PTK7 was also found in a second independent
proteomic study (Figure S1A; Table S1).
High PTK7 Expression Levels Segregate with High
Self-Renewal Capacity in Ex Vivo Cultured Human
Colonic Crypts
In a previous study, we observed that only around 5%–6%
of viable cells within human colonic organoids cultured in
WREN media hold the capacity to reform organoids upon
serial passaging (Jung et al., 2011). Our data suggested
that only a subpopulation of organoid cells remains as
bona fide stem cells (Jung et al., 2011). Flow-cytometry
analysis of these cultures revealed heterogeneous surface(B) Volcano plot of statistical significance (log10 p value) against
cultures maintained in either WREN or EN media. Negative fold change
data).
See Figure S1 and Table S1 for an additional experiment.
(C) Fractionation of single cells from in vitro cultured organoids by FAC
Medium, green: PTK7-Neg) (upper). Same cell numbers of each fraction
assessed (bottom).
(D) Estimated frequencies of organoid-initiating cells (OIC) in differe
isolated according to PTK7 surface abundance. 40, 150, and 400 cell
applying the maximum-likelihood estimation method of limiting dilu
(E) Quantitative real-time PCR (qRT-PCR) analysis of stem cell, prolife
different fractions of organoid cells purified according to PTK7 levels
Error bars indicate SD (n = 3 technical replicates, see Figures 2 and S
(F) qRT-PCR analysis of LGR5 and differentiation marker gene expr
expanded in WREN media, and maintained under EN media for 5 days
Stem Cellexpression of PTK7 (Figure 1C, upper). We found that
cells with high PTK7 surface abundance exhibited a higher
re-seeding capacity when compared with PTK7-low, or
PTK7-negative cells (Figures 1C, 2B, S1B, and S2B). To
determine the frequency of organoid re-initiating cells
(OIC) of each PTK7 population, we plated different cell
numbers (40, 150, and 400 viable cells) and counted the
number of organoids after 1 week. We then calculated
OIC frequencies by applying themaximum-likelihood esti-
mationmethod for limiting dilutions assay (Hu and Smyth,
2009). Simply re-plating the total of viable cells yielded a
frequency of one OIC every 34 cells (3%), in line with our
previous observations (Jung et al., 2011). We calculated
an OIC of 1 in 6 for PTK7-high (16.7%), 1 in 23 for PTK7-
low (4.3%), and 1 in 118 (0.85%) for PTK7-negative cells
(Figure 1D). Furthermore, PTK7-high cells expressed
elevated levels of bona fide ISC marker genes such as
LGR5 and ASCL2 (Figure 1E, left), whereas PTK7-low and
PTK7-negative WREN-cultured organoid cells expressed
relatively higher levels of intestinal differentiation genes,
including ANPEP, CEACAM7, and CA1 (Figure 1E, right).
Upon removal of growth factors, secondary organoid cul-
tures derived fromPTK7-high cells underwentmultilineage
differentiation (Figure 1F).
We and others have previously identified surfacemarkers
for purification of mouse and human adult stem cells from
intestinal samples. These include EPHB2 (Jung et al., 2011;
Merlos-Sua´rez et al., 2011), CD44 (Gracz et al., 2013; Wang
et al., 2013), and Prominin-1/CD133 (Hou et al., 2011; Zhu
et al., 2009). These markers showed heterogeneous surface
expression in human colonic organoid cultures main-
tained in WREN media (Figures 2A and S2A). We thus as-
sessed organoid-forming capacity of cells isolated using
these surface markers by fluorescence-activated cell sorting
(FACS). We compared the 10% more positive versus 20%
more negative population for each of these markers within
the same organoid culture. This experiment demonstratedfold-change (log2 fold change) between human colonic organoid
s represent organoid stem cell-enriched proteins (see Table S1 for all
S according to PTK7 surface abundance (blue: PTK7-High, red: PTK7-
were seeded, and the corresponding organoid-forming capacity was
nt subpopulations of in vitro grown human colonic organoid cells
s of each fraction were plated, and frequencies were calculated by
tions assay (Hu and Smyth, 2009). CI, confidence interval.
ration (left), and differentiation marker (right) gene expression on
in (C).
2 for supporting results). n.d., not detectable.
ession in organoid cells purified according to PTK7 levels in (C),
. Error bars indicate SD (n = 3 biological replicates).
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Figure 2. Comparison of PTK7 to Other Stem Cell Markers Proofs Enhanced Capacity to Enrich for Self-Renewing Organoid Cells
(A) Human colonic organoids maintained in WREN media were disaggregated and stained against the indicated surface markers. Via FACS,
9%–10% of cells showing the brightest staining intensity (HIGH) and 20%–21% of cells showing the weakest intensity (LOW) were
isolated. Control (transparent profile) and specific staining (gray profile) are shown in each histogram.
See Figures S2A–S2C for an equivalent experiment derived from a different individual.
(B) Organoid formation capacity of cellular fractions isolated via FACS as shown in (A). Each cellular fraction was seeded four times
(biological replicate), and the frequency of organoid formation was assessed 8 days after seeding. Error bars indicate SEM. Significance of
PTK7 high versus low enrichment over EPHB2, CD44, or CD133 performance was assessed using the F-test (Supplemental Experimental
Procedures). *p < 0.02.
(C) qRT-PCR analysis of stem cell and differentiation marker gene expression on organoid cells HIGH and LOW for the indicated marker
surface abundance according to (A) (see also Figure S2). Gene expression was assessed three times (technical replicate), and error bars
indicate SD.PTK7-high cells contained significantly more organoid
forming cells than equivalent populations purified with
the other ISC markers (Figure 2B). In addition, PTK7-high
cells displayed higher expression levels of ISC markers
genes (LGR5, SMOC2) and decreased expression of differen-
tiation markers (KRT20, FABP2) compared with EPHB2-
high, CD44-high, and CD133-high cells (Figure 2C). We
obtained equivalent results using organoids derived from
a different individual (Figure S2). Our data indicate that hu-982 Stem Cell Reports j Vol. 5 j 979–987 j December 8, 2015 j ª2015 The Aman colonic organoids inWRENmedia contain phenotyp-
ically distinct cell populations and that high PTK7 surface
levels specify bona fide stem cells in these cultures.
PTK7 Enriches in Self-Renewing, Multipotent Stem
Cells of the Human Colon
Immunohistochemical analysis confirmed that PTK7 anti-
bodies stained the bottom third of human colonic crypts
with the highest intensity observed at the bottommostuthors
positionswhere stem cells reside (Figures 3A and S3A). PTK7
expressionwasmore restricted to the crypt base than that of
EPHB2 (Figure 3B), which is the standard surface marker
used in the field for the purification of hCoSCs (Jung
et al., 2011). In addition, PTK7+ cells were negative for
KRT20, MUC2, or FABP1 and CA2 (pan, mucosecreting, or
absorptive differentiation markers, respectively) (Figures
3C, 3D, S4A, and S4B). These results encouragedus to isolate
different cell fractions based on PTK7 surface abundance
directly from human samples of patients undergoing colec-
tomy. As in organoid cultures, human epithelial colonic
cells (EpCAM-positive and CD11/CD31/CD45-negative)
displayed heterogeneous PTK7 surface expression (Fig-
ure 3E). We counted the number of organoids generated
by PTK7-high, PTK7-med, PTK7-low, and PTK7-neg intesti-
nal epithelial cells in WREN media (Figure 3F). This experi-
ment demonstrated that highest de novo organoid-forming
capacity co-segregated with elevated PTK7 surface levels
(n = 3 independent mucosa cultures; Figure 3G). When
cultured and serially passaged for several weeks under
WREN conditions, PTK7-high single cell-derived human
colonic organoids maintained the ability to differentiate
into absorptive and secretory lineages (Figure S3B). PTK7-
high cells expressed elevated levels of the ISC markers
LGR5 and ASCL2 (Figures 3H and S3C). Therefore, PTK7
expression is highest in human CoSCs and can be utilized
to purify this cell population fromhumanmucosal samples.
PTK7-High hCoSCs Display Genetic Features of
Canonical ISCs and of LRCs
Transcriptomic profiling of PTK7-high cells directly puri-
fied from fresh human mucosa samples confirmed enrich-
ment inmost genes characteristic of mouse ISCs, including
LGR5 (Barker et al., 2007),ASCL2 (van der Flier et al., 2009),
and SMOC2 (Mun˜oz et al., 2012) (Table S3). Yet, we also
noticed that severalmarkers of the enteroendocrine lineage
such as CHGA and CHGB were upregulated in human
PTK7-high cells (Figures 3H and S4E; Table S3). Immunoflu-
orescence on human mucosa tissue sections confirmed
that a small proportion (9%on average) of PTK7+ cells posi-
tioned at the crypt base co-expressed CHGA (n = 76 crypts
analyzed from two different individuals; data not shown),
with some crypts showing up to four PTK7/CHGA dou-
ble-positive cells at their base (Figures 4A and S4C). Recent
characterization of the mouse ISC niche has identified a
subpopulation of Lgr5+ cells in the small intestine undergo-
ing direct differentiation toward enteroendocrine and Pan-
eth cell lineages (Buczacki et al., 2013; Gru¨n et al., 2015).
They are termed LRCs because, as a result of slower prolifer-
ation rates, they do not dilute DNA labeling molecules. We
thus sought to clarify whether PTK7 alsomarks LRCs in the
mouse intestine. None of the commercially available anti-
PTK7 antibodies recognized the mouse protein, which pre-Stem Cellcluded isolation of PTK7+ cells by flow cytometry from
mouse tissues (data not shown). Therefore, we used
Cyp1a1-H2B-YFP mice, which upon induction with beta-
Naphthoflavone, express histone H2B-YFP fusion protein
in intestinal cells (Buczacki et al., 2013). In pulse-chase ex-
periments, around 8%–10% of CD24+/Lectin crypt cells
retained the H2B-YFP label 10 days after induction (Figures
4B and 4C). Mouse SI LRCs (CD24+/H2BYFP+) expressed
Lgr5, Chga, and Rfx6 compared with non-LRCs (CD24+/
H2BYFP). This experiment revealed that LRCs also ex-
pressed high levels of Ptk7 (Figure 4D).
To extend our analysis, we studied the expression of
genes characteristic of mouse Lgr5+ ISCs (Mun˜oz et al.,
2012) or of LRCs (Buczacki et al., 2013) in PTK7+ hCoSCs.
We derived an ISC (LGR5) signature comparing the tran-
scriptomic profiles of Lgr5-GFP-high versus Lgr5-GFP-low
crypt cells purified from Lgr5-GFP knockin mice (Mun˜oz
et al., 2012) (Table S4). This gene set contained many
WNT targets, including the ISC marker genes LGR5,
SMOC2, ASCL2, and APCDD1. To generate a specific LRC
signature, we selected genes upregulated in H2B-YFP-re-
taining crypt cells (H2BYFP+; CD24+) compared with
crypt non-retaining cells (H2BYFP; CD24+) (Table S4;
Supplemental Experimental Procedures for details) (Buc-
zacki et al., 2013). Only 12 genes overlapped between the
LGR5 and LRC gene sets (Figure 4E). Gene Set Enrichment
Analysis (GSEA) showed that both signatures were highly
enriched in PTK7-high hCoSCs cells (Figures 4F and S4D).
We confirmed by qRT-PCR that genes specific of LRCs,
such as CHGA, TPH1, RFX6, and CACNA1A, were upregu-
lated in PTK7-high cells compared with PTK7-low cells pu-
rified from human colon samples (Figure 4G). In contrast,
EPHB2-high or CD44-high cells purified from these sam-
ples were not enriched in LRC-specific genes (Figures S4E
and S4F). These results indicate that the PTK7+ human
colonic epithelial cell population expresses gene programs
of both canonical ISCs and of LRCs.DISCUSSION
Insertion of reporter cassettes into the Lgr5 locus has
enabled characterization of mouse ISCs (Barker et al.,
2007, 2010) and development of ex vivo organoid culture
systems (Sato et al., 2009). Subsequent transplantation as-
says using fetal or adult ISCs have paved the way for regen-
erative therapies of intestinal injuries (Fordham et al.,
2013; Yui et al., 2012). However, low cell surface abundance
of the LGR5 protein and lack of high-affinity anti-LGR5 an-
tibodies represent a roadblock to isolate human colon stem
cells using this marker gene. Our data show that PTK7 is a
surrogate of LGR5 in human colon. The methodology
developed herein enables the isolation of a cell populationReports j Vol. 5 j 979–987 j December 8, 2015 j ª2015 The Authors 983
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Figure 3. PTK7 Specifies Self-Renewing, Multipotent Stem Cells of the Human Colon
(A–D) Immunohistochemistry analysis of (A) PTK7, (B) EPHB2, (C) FABP1, and (D) CK20 expression on serial sections of normal human
colonic mucosa. Black arrows indicate specific staining. Scale bar represents 100 mm.
(E) FACS profile of single-cell suspensions from primary human colon stained with antibody to PTK7 (APC-conjugate) (upper). Only
epithelial cells were included (EpCAM+) and non-epithelial cells were excluded (CD11/CD31/CD45) from the analysis. Control staining
was performed to define PTK7-negative fraction (lower). H, PTK7 high; M, PTK7 medium; L, PTK7 low; N, PTK7 negative.
(F) Representative images of organoid cultures 10 days after seeding equal cell numbers.
(G) Quantification of organoid-forming capacity of colon cells sorted in (E). Shown are data collected from three independent 3D cultures
(biological replicates). t test, *p value of the average PTK7 high versus average medium lower than 0.05.
(H) qRT-PCR analysis of gene expression on primary human colon epithelial cells purified by FACS according to different PTK7 surface levels.
Error bars indicate SD (n = 3 technical replicates, see Figure S3C for an additional supporting experiment).
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largely enriched in CoSCs from human mucosa samples.
Remarkably, the possibility of purifying the cell population
with highest self-renewal capacity from organoid cultures
through PTK7 could facilitate the development of thera-
peutic approaches based on CoSC transplantation.
Identification of a pool of slow cycling ISCs committed to
differentiate toward Paneth and enteroendocrine lineages
has clarified the long-lasting debate about the existence of
quiescent stem cells in the intestine (Clevers, 2013b). One
of the defining features of intestinal LRCs is the ability to
gain multipotent growth capacity upon tissue injury (Buc-
zacki et al., 2013). However, it remains unclear whether a
similar cell type is also present in the human intestine.
Expression profiling of PTK7-high cell population suggests
the existence of LRC-like cells in the human colonic epithe-
lium and implies phenotypic and functional heterogeneity
within the hCoSC compartment similar to that present in
mouse crypts. Importantly, Buczacki et al. (2013) demon-
strated that mouse LRCs maintain the ability to form intes-
tinal organoids when plated in the culture dish. However,
under these conditions, LRCs lose their quiescent/slow-
cycling character and revert into actively proliferating
ISCs (Buczacki et al., 2013). Similarly, we were unable to
identify LRCs in human colon organoids (data not shown).
Future efforts should aim to optimize organoid culture con-
ditions in order to promote the concomitant propagation of
canonical stem cells and LRCs in vitro. The biology of these
reserve stem cells in humans holds great interest as they
might be responsible for regeneration of human colon mu-
cosa upon certain insults such as chemotherapy.EXPERIMENTAL PROCEDURES
Organoid Cultures from Colonic Crypts
Colonic tissue pieces were incubated in 10 mM DTT for 5 min at
room temperature and transferred to 8 mM EDTA for 60 min at
4C, and vigorous shaking yielded supernatants enriched in(B) Experimental scheme. Mice were given three consecutive intrap
24 hr. At day 10, animals were killed and small intestinal (SI) crypt c
(C) FACS profile of single cell suspension derived from Cyp1a1-H2B-Y
divided into YFP-positive label-retaining cells (LRCs) and YFP-negati
(D) qRT-PCR expression analysis showing mouse SI label-retaining c
expression compared to CD24+/YFP cells. Shown are two independ
analyzed three times (technical replicate), and error bars indicate SD
(E) Venn diagram showing genes that overlap between the humanize
label-retaining cell (LRC) signature (Doug Winton Lab).
(F) GSEA analysis was performed using the specific canonical (LGR5
plemental Experimental Procedures) for our PTK7 hCoSC microarray d
See Figure S4D for an independent experiment performed on a differe
(G) qRT-PCR expression analysis showing that PTK7-high human colo
PTK7-low cells. Samples derived from one patient were analyzed thre
See Figures S4E and S4F for additional supporting data.
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